|
Strides Pharma Science Ltd.
|
Cash Flow
|
|
|
You can view the
Cash Flow
for the last 5 years.
|
Market Cap. (Rs.)
|
11540.02 Cr.
|
P/BV
|
3.52
|
Book Value (Rs.)
|
355.24
|
|
52 Week High/Low (Rs.)
|
1231/769
|
FV/ML
|
10/1
|
P/E(X)
|
20.75
|
|
Bookclosure
|
31/07/2026
|
EPS (Rs.)
|
60.34
|
Div Yield (%)
|
0.40
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| Net Profit/Loss Before Extraordinary Items And Tax | 668.69 | 3675.03 | -116.94 | -286.20 | -652.51 |
| | | | | | |
| Net CashFlow From Operating Activities | 702.52 | 684.37 | 701.07 | 44.41 | -257.82 |
| Net Cash Used In Investing Activities | -173.04 | -89.69 | -150.25 | 302.47 | -118.73 |
| Net Cash Used From Financing Activities | -453.41 | -642.58 | -693.32 | -213.92 | 421.32 |
| Foreign Exchange Gains / Losses | 0.06 | -0.54 | 0.16 | 0.15 | 0.13 |
| Adjustments On Amalgamation / Merger / Demerger And Others | 0.00 | -0.02 | -0.14 | -0.34 | 0.00 |
| | | | | | |
| Net Inc/Dec In Cash And Cash Equivalents | 76.13 | -48.46 | -142.48 | 132.77 | 44.90 |
| Cash And Cash Equivalents Begin of Year | 112.56 | 161.02 | 303.50 | 170.73 | 125.83 |
| Cash And Cash Equivalents End Of Year | 188.70 | 112.56 | 161.02 | 303.50 | 170.73 |
